Justice-sector AI / United States / U.S. Department of Justice — Drug Enforcement Administration

DEA Drug Signature Program Models

U.S. Department of Justice — Drug Enforcement Administration · Police and forensics · 2025

status as stated: DeployedUse-case inventory entryGenerative AI

The DOJ 2025 inventory lists DEA Drug Signature Program Models for U.S. Department of Justice — Drug Enforcement Administration. The row states the stage as Deployed; it classifies the use case as Generative AI for Law Enforcement and says it addresses Understanding the manufacturing origin and distribution route of illicit…

Understanding the manufacturing origin and distribution route of illicit drugs by analyzing the chemical composition of seized drugs is a core DEA task. The purpose of this use case is to use AI/ML techniques to develop, maintain, and improve models that enable designated forensic chemists to identify a notional geographic origin or notional manufacturing route of samples selected for DEA's Drug Signature Programs.

Status date given by the source: 01/1998.

Official record: justice.gov · archived copy
Read: 2026-09-07 · primary document read
Found via: doj-inventory-2025
Notes: DOJ spreadsheet row DOJ-0060; original component field: Department of Justice / DEA.

United States federal record — public domain (17 U.S.C. §105). The status word is the source's own on the read date; a pilot is not recorded as a deployment and a contract is not recorded as use. This record summarises a public court document or official publication and reports what it says; SafeLegalAI makes no findings of its own. Individuals and organisations are named only as they appear in that public record. Anyone named may send a right of reply, correction or contextual update (for example an appeal, vacatur or later disposition) via /report; we add a dated note where appropriate. Reply or correct this record.

compiled by the Cognesio LLP editorial teammethodas of 2026-09-07v0.1.1coding CC BY 4.0JSON Hugging Face GitHub